Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DB25FZX64
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,881
Award facts
- Contract value 100% obligated
- $3,881.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,881.10 by the Defense Logistics Agency on August 14, 2025, for the supply of Botox 200 unit vials. The contract, which has no set-aside designation, is scheduled for completion by September 5, 2025, with performance taking place in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with DLA under the SPE2DB program, valued at approximately $500 million and extending through November 2026.
The Defense Logistics Agency utilizes this IDC vehicle to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables, to support the medical supply needs of Department of Defense healthcare facilities worldwide. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group has demonstrated consistent success in securing delivery orders for specialized medical products, including oncology treatments, vaccines, and injectable medications, that directly support military health system operations. The award reflects the vendor's established capability and positioning as a preferred supplier for DLA's pharmaceutical procurement requirements.
Quick answers
Who was awarded contract SPE2DB25FZX64?
SPE2DB25FZX64 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 14, 2025.
How much is contract SPE2DB25FZX64 worth?
The government has obligated $3,881 on SPE2DB25FZX64.
Is contract SPE2DB25FZX64 an order under another contract?
Yes. SPE2DB25FZX64 is a delivery order under SPE2DB20D9135, an indefinite delivery contract.
Was contract SPE2DB25FZX64 competed?
The extent of competition for SPE2DB25FZX64 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award